Last reviewed · How we verify
Matronal (methylestrenolone)
Matronal (generic name: methylestrenolone) is a methylestrenolone drug. It is currently in unknown development.
Matronal works by binding to and activating the androgen receptor, mimicking the effects of male sex hormones.
Matronal is a small molecule medication used in combination with an estrogen to treat amenorrhea and menopausal symptoms in women. It is taken by mouth and is a progestin and androgen/anabolic steroid medication.
At a glance
| Generic name | methylestrenolone |
|---|---|
| Drug class | methylestrenolone |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body has locks on the cells that control muscle growth and development. Matronal is a key that fits into these locks, allowing the cells to receive signals that promote muscle growth and strength. This can be beneficial for people who need to build muscle mass, but it can also have negative effects if not used carefully.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Matronal CI brief — competitive landscape report
- Matronal updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Matronal
What is Matronal?
How does Matronal work?
What is the generic name of Matronal?
What drug class is Matronal in?
What development phase is Matronal in?
Related
- Drug class: All methylestrenolone drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing